147 related articles for article (PubMed ID: 35104873)
1. Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP
J Infect Dis; 2022 Aug; 226(2):236-245. PubMed ID: 35104873
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
[TBL] [Abstract][Full Text] [Related]
3. Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations.
Zheng L; Tierney C; Bosch RJ
Curr HIV/AIDS Rep; 2021 Oct; 18(5):475-482. PubMed ID: 34213731
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
Julg B; Dee L; Ananworanich J; Barouch DH; Bar K; Caskey M; Colby DJ; Dawson L; Dong KL; Dubé K; Eron J; Frater J; Gandhi RT; Geleziunas R; Goulder P; Hanna GJ; Jefferys R; Johnston R; Kuritzkes D; Li JZ; Likhitwonnawut U; van Lunzen J; Martinez-Picado J; Miller V; Montaner LJ; Nixon DF; Palm D; Pantaleo G; Peay H; Persaud D; Salzwedel J; Salzwedel K; Schacker T; Sheikh V; Søgaard OS; Spudich S; Stephenson K; Sugarman J; Taylor J; Tebas P; Tiemessen CT; Tressler R; Weiss CD; Zheng L; Robb ML; Michael NL; Mellors JW; Deeks SG; Walker BD
Lancet HIV; 2019 Apr; 6(4):e259-e268. PubMed ID: 30885693
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
[TBL] [Abstract][Full Text] [Related]
6. Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency Virus.
Hellmuth J; Muccini C; Colby DJ; Kroon E; de Souza M; Crowell TA; Chan P; Sacdalan C; Intasan J; Benjapornpong K; Tipsuk S; Puttamaswin S; Chomchey N; Valcour V; Sarnecki M; Tomaka F; Krebs SJ; Slike BM; Jagodzinski LL; Dumrongpisutikul N; Sailasuta N; Samboju V; Michael NL; Robb ML; Vasan S; Ananworanich J; Phanuphak P; Phanuphak N; Paul R; Spudich S
Clin Infect Dis; 2021 Oct; 73(7):e1885-e1892. PubMed ID: 32916708
[TBL] [Abstract][Full Text] [Related]
7. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
[TBL] [Abstract][Full Text] [Related]
8. Acute HIV-1 infection viremia associate with rebound upon treatment interruption.
Mdluli T; Li Y; Pinyakorn S; Reeves DB; Cardozo-Ojeda EF; Yates A; Intasan J; Tipsuk S; Phanuphak N; Sacdalan C; Colby DJ; Kroon E; Crowell TA; Thomas R; Robb ML; Ananworanich J; de Souza M; Phanuphak P; Stieh DJ; Tomaka FL; Trautmann L; Ake JA; Hsu DC; Francisco LV; Vasan S; Rolland M
Med; 2022 Sep; 3(9):622-635.e3. PubMed ID: 35870446
[TBL] [Abstract][Full Text] [Related]
9. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption.
Prator CA; Thanh C; Kumar S; Pan T; Peluso MJ; Bosch R; Jones N; Milush JM; Bakkour S; Stone M; Busch MP; Deeks SG; Hunt PW; Henrich TJ
J Infect Dis; 2020 Mar; 221(7):1146-1155. PubMed ID: 31677350
[TBL] [Abstract][Full Text] [Related]
10. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from HIV antiretroviral treatment interruption trials.
Wen Y; Bar KJ; Li JZ
Curr Opin HIV AIDS; 2018 Sep; 13(5):416-421. PubMed ID: 29878912
[TBL] [Abstract][Full Text] [Related]
12. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA.
Strongin Z; Sharaf R; VanBelzen DJ; Jacobson JM; Connick E; Volberding P; Skiest DJ; Gandhi RT; Kuritzkes DR; O'Doherty U; Li JZ
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593048
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.
Sneller MC; Huiting ED; Clarridge KE; Seamon C; Blazkova J; Justement JS; Shi V; Whitehead EJ; Schneck RF; Proschan M; Moir S; Fauci AS; Chun TW
J Infect Dis; 2020 Oct; 222(10):1655-1659. PubMed ID: 32443148
[TBL] [Abstract][Full Text] [Related]
14. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
[No Abstract] [Full Text] [Related]
15. Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.
Corley MJ; Pang APS; Rasmussen TA; Tolstrup M; Søgaard OS; Ndhlovu LC
AIDS; 2021 Nov; 35(14):2269-2279. PubMed ID: 34482353
[TBL] [Abstract][Full Text] [Related]
16. Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption.
Alexandre M; Prague M; Lhomme E; Lelièvre JD; Wittkop L; Richert L; Lévy Y; Thiébaut R
Clin Infect Dis; 2024 May; ():. PubMed ID: 38819800
[TBL] [Abstract][Full Text] [Related]
17. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
Palich R; Ghosn J; Chaillon A; Boilet V; Nere ML; Chaix ML; Delobel P; Molina JM; Lucht F; Bouchaud O; Rieux V; Thiebaut R; Levy Y; Delaugerre C; Lelievre JD;
AIDS; 2019 Feb; 33(2):279-284. PubMed ID: 30325777
[TBL] [Abstract][Full Text] [Related]
18. Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
Clarridge KE; Blazkova J; Einkauf K; Petrone M; Refsland EW; Justement JS; Shi V; Huiting ED; Seamon CA; Lee GQ; Yu XG; Moir S; Sneller MC; Lichterfeld M; Chun TW
PLoS Pathog; 2018 Jan; 14(1):e1006792. PubMed ID: 29324842
[TBL] [Abstract][Full Text] [Related]
19. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
Papasavvas E; Lada SM; Joseph J; Yin X; Liu Q; Azzoni L; Mounzer K; Kostman JR; Richman D; Montaner LJ
AIDS; 2018 Aug; 32(13):1763-1772. PubMed ID: 30045057
[TBL] [Abstract][Full Text] [Related]
20. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
